BlueLinx (BXC) had the highest return between January 10, 2018 and March 12, 2018 by a small-cap US stock, returning 170.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
BlueLinx (BXC) | 1/10/2018 - 3/12/2018 | 170.56% |
Acm Research (ACMR) | 1/10/2018 - 3/12/2018 | 147.81% |
POET Technologies (POET) | 1/10/2018 - 3/12/2018 | 147.06% |
Iovance Biotherapeutics (IOVA) | 1/10/2018 - 3/12/2018 | 126.63% |
Fubotv (FUBO) | 1/10/2018 - 3/12/2018 | 88.37% |
Vericel Corp Ord (VCEL) | 1/10/2018 - 3/12/2018 | 86.67% |
Gyre Therapeutics (GYRE) | 1/10/2018 - 3/12/2018 | 84.5% |
Intellia Therapeutics (NTLA) | 1/10/2018 - 3/12/2018 | 71% |
American Public Education (APEI) | 1/10/2018 - 3/12/2018 | 69.84% |
Perpetua Resources (PPTA) | 1/10/2018 - 3/12/2018 | 67.87% |
Spyre Therapeutics (SYRE) | 1/10/2018 - 3/12/2018 | 67.32% |
InnovAge (INNV) | 1/10/2018 - 3/12/2018 | 60.56% |
Novavax (NVAX) | 1/10/2018 - 3/12/2018 | 59.26% |
Geron (GERN) | 1/10/2018 - 3/12/2018 | 56.68% |
Kura Oncology (KURA) | 1/10/2018 - 3/12/2018 | 55.52% |
Dine Brands Global (DIN) | 1/10/2018 - 3/12/2018 | 52.91% |
Nektar Therapeutics (NKTR) | 1/10/2018 - 3/12/2018 | 52.4% |
Xencor (XNCR) | 1/10/2018 - 3/12/2018 | 48.94% |
Rocket Pharmaceuticals (RCKT) | 1/10/2018 - 3/12/2018 | 47.95% |
QuinStreet (QNST) | 1/10/2018 - 3/12/2018 | 46.95% |
SolarEdge Technologies (SEDG) | 1/10/2018 - 3/12/2018 | 45.95% |
Larimar Therapeutics (LRMR) | 1/10/2018 - 3/12/2018 | 44.28% |
Neurogene (NGNE) | 1/10/2018 - 3/12/2018 | 44.23% |
Onity (ONIT) | 1/10/2018 - 3/12/2018 | 44.04% |
Liquidity Services (LQDT) | 1/10/2018 - 3/12/2018 | 44% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
